60 Degrees Pharmaceuticals, Inc. (SXTPW) — DEF 14A Filings
All DEF 14A filings from 60 Degrees Pharmaceuticals, Inc.. Browse 3 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (3)
-
60 Degrees Pharma Proposes Reverse Split, Boosts Equity Plan
— Aug 27, 2025 Risk: high
60 Degrees Pharmaceuticals, Inc. (SXTPW) is holding its 2025 Annual Meeting on October 8, 2025, virtually via live audio webcast. Key proposals include the elec -
60 Degrees Pharma Files Proxy Statement
— Oct 15, 2024 Risk: low
60 Degrees Pharmaceuticals, Inc. filed a definitive proxy statement on October 15, 2024, for their annual meeting on November 6, 2024. The company is seeking sh -
60 Degrees Pharma Files Proxy Statement for July Meeting
— May 30, 2024 Risk: low
60 Degrees Pharmaceuticals, Inc. filed a Definitive Proxy Statement (DEF 14A) on May 30, 2024, for its annual meeting scheduled for July 16, 2024. The filing ou
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX